205 related articles for article (PubMed ID: 19220487)
1. Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators.
Evans DE; Park JY; Maxfield N; Drobes DJ
Genes Brain Behav; 2009 Feb; 8(1):86-96. PubMed ID: 19220487
[TBL] [Abstract][Full Text] [Related]
2. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
[TBL] [Abstract][Full Text] [Related]
3. P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics.
Ratsma JE; van der Stelt O; Schoffelmeer AN; Westerveld And A; Boudewijn Gunning W
Alcohol Clin Exp Res; 2001 Jul; 25(7):960-7. PubMed ID: 11505019
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
Knott V; Millar A; Fisher D; Albert P
Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.
Vandenbergh DJ; O'Connor RJ; Grant MD; Jefferson AL; Vogler GP; Strasser AA; Kozlowski LT
Addict Biol; 2007 Mar; 12(1):106-16. PubMed ID: 17407504
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
7. P300 development during adolescence: effects of DRD2 genotype.
Berman SM; Noble EP; Antolin T; Sheen C; Conner BT; Ritchie T
Clin Neurophysiol; 2006 Mar; 117(3):649-59. PubMed ID: 16426891
[TBL] [Abstract][Full Text] [Related]
8. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
[TBL] [Abstract][Full Text] [Related]
9. Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.
Kleinjan M; Engels RC; DiFranza JR
BMC Pulm Med; 2015 Oct; 15():115. PubMed ID: 26449981
[TBL] [Abstract][Full Text] [Related]
10. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S
Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271
[TBL] [Abstract][Full Text] [Related]
11. The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
Chan PY; Davenport PW
J Appl Physiol (1985); 2010 Mar; 108(3):662-9. PubMed ID: 20056851
[TBL] [Abstract][Full Text] [Related]
12. The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.
Johnstone EC; Yudkin P; Griffiths SE; Fuller A; Murphy M; Walton R
Addict Biol; 2004; 9(3-4):221-6. PubMed ID: 15511716
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evidence of nicotine's distracter-filtering properties in non-smokers.
Knott V; Heenan A; Shah D; Bolton K; Fisher D; Villeneuve C
J Psychopharmacol; 2011 Feb; 25(2):239-48. PubMed ID: 19939874
[TBL] [Abstract][Full Text] [Related]
14. D2 dopamine receptor (DRD2) gene, P300, and personality in children of alcoholics.
Antolin T; Berman SM; Conner BT; Ozkaragoz TZ; Sheen CL; Ritchie TL; Noble EP
Psychiatry Res; 2009 Apr; 166(2-3):91-101. PubMed ID: 19278736
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
Knott VJ; Fisher DJ
Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
[TBL] [Abstract][Full Text] [Related]
16. The acute effects of nicotine on positive and negative affect in adolescent smokers.
Kassel JD; Evatt DP; Greenstein JE; Wardle MC; Yates MC; Veilleux JC
J Abnorm Psychol; 2007 Aug; 116(3):543-53. PubMed ID: 17696710
[TBL] [Abstract][Full Text] [Related]
17. Use of eye movement to measure smokers' attentional bias to smoking-related cues.
Kwak SM; Na DL; Kim G; Kim GS; Lee JH
Cyberpsychol Behav; 2007 Apr; 10(2):299-304. PubMed ID: 17474851
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing.
Gilbert DG; Izetelny A; Radtke R; Hammersley J; Rabinovich NE; Jameson TR; Huggenvik JI
Nicotine Tob Res; 2005 Jun; 7(3):361-79. PubMed ID: 16085504
[TBL] [Abstract][Full Text] [Related]
19. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.
Cole DM; Beckmann CF; Long CJ; Matthews PM; Durcan MJ; Beaver JD
Neuroimage; 2010 Aug; 52(2):590-9. PubMed ID: 20441798
[TBL] [Abstract][Full Text] [Related]
20. Nicotine Stroop and addiction memory--an ERP study.
Fehr T; Wiedenmann P; Herrmann M
Int J Psychophysiol; 2006 Nov; 62(2):224-32. PubMed ID: 16492391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]